Active substances
Clioquinol + Hydrocortisone
- SFDA 2
- Health Canada 1
SFDA Saudi Arabia — SFDA human drug list
| Trade name | Strength | Form · route | Pack | Public price | Type | Company | Status |
|---|---|---|---|---|---|---|---|
| CLIOCORT | 1,3 %,% | Rectal ointment · Topical | 1 Bottle | SAR 16.75 | Generic · Prescription | RIYADH PHARMA | Valid |
| VIOFORM-HYDROCORTISONE CREAM | 0.5, 3 % | Cream · Topical | 1 Tube | SAR 15.10 | Generic · Prescription | NOVARTIS | Withdrawn by MAH · Not Marketed |
Indications — CHI Daman Drug Formulary
ECZEMA
Canada Canada — marketed products (Health Canada)
| Brand | DIN | Strength | Form · route | Company |
|---|---|---|---|---|
| VIOFORM HYDROCORTISONE | 00074500 | 3 % / W/W; 1 % / W/W | CREAM · TOPICAL | KNIGHT THERAPEUTICS INC. |
Components
Values as published by each source: SFDA human drug list (4-2026, as published by the Council of Health Insurance; indications from the CHI Daman Drug Formulary), Drugs@FDA, EMA medicines data, Health Canada Drug Product Database (Open Government Licence – Canada), CMS NADAC, NHS Drug Tariff Part VIIIA (NHSBSA Copyright, Open Government Licence v3.0), WHO Model List of Essential Medicines (CC BY 3.0 IGO; regrouped by active substance, not created by WHO), EMA PRAC, US FDA safety-related labeling changes and MHRA Drug Safety Update (Open Government Licence v3.0). Sources and reuse. Not a substitute for the official registers or the product information.